Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 119.41
   
  • Change Today:
    $9.13
  • 52 Week High: $121.38
  • 52 Week Low: $114.80
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 13,115,287
  • Market Cap: $148,785m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 119.41
Change Today $ 9.13
% Change 8.28 %
52 Week High $121.38
52 Week Low $114.80
Volume 13,115,287
Shares Issued 1,246.00m
Market Cap $148,785m
RiskGrade 120

What The Brokers Say

Strong Buy 10
Buy 10
Neutral 7
Sell 1
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 08-Aug-2025

Time Volume / Share Price
15:59 154 @ $119.40
15:59 146 @ $119.40
15:59 100 @ $119.39
15:59 100 @ $119.39
15:59 1,909 @ $119.37

Top of Page